TVTX
Travere Therapeutics Inc
60.60$
+1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2.0% | 2.2% | 3.4% | 2.3% | 3.4% | 3.0% | 3.1% | 2.9% | 4.0% | 7.9% | 3.3% | 2.1% | |
| 98.0% | 97.8% | 96.6% | 97.7% | 96.6% | 97.0% | 96.9% | 97.1% | 96.0% | 92.1% | 96.7% | 97.9% | |
| 169.5% | 50.5% | 53.0% | 50.5% | 75.3% | 80.4% | 66.4% | 152.6% | 207.7% | 168.7% | 121.2% | 42.0% | |
| 211.5% | 79.6% | 73.4% | 67.1% | 63.1% | 73.5% | 68.5% | 95.8% | 180.4% | 182.8% | 113.3% | 68.7% | |
| 380.9% | 130.1% | 126.4% | 117.5% | 138.5% | 153.9% | 185.7% | 248.4% | 388.1% | 359.4% | 235.6% | 110.7% | |
| -283.0% | -50.8% | -43.6% | -34.7% | -48.7% | -56.9% | -88.8% | -151.3% | -292.2% | -267.2% | -138.9% | -12.8% | |
| 195.1% | 19.5% | 3.5% | 2.9% | 6.0% | 10.7% | 9.6% | 14.9% | 10.1% | 7.8% | 4.8% | 2.2% | |
| -402.1% | 105.6% | -43.1% | -37.7% | -62.0% | -83.5% | -95.2% | -164.5% | -302.5% | -259.0% | -137.5% | -10.0% | |
| -8.7% | -11.8% | -7.2% | 0.9% | 0.5% | 0.0% | -9.8% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% | |
| -393.4% | 117.4% | -35.9% | -38.6% | -62.5% | -83.5% | -85.4% | -136.6% | -254.4% | -76.7% | -137.9% | -5.2% | |
| -262.8% | 129.6% | -29.0% | -25.0% | -44.7% | -61.1% | -73.2% | -139.9% | -273.5% | -224.6% | -114.0% | 4.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.